E-Voting Results and Scrutinizer Report of 42nd AGM
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals held its 42nd AGM on September 9, 2025 via video conferencing from 12:00 PM to 12:50 PM, with all 11 resolutions passed with requisite majority. Key items approved include adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, re-appointment of retiring directors Mr. Ajay Kumar Arora and Mrs. Geeta Arora, appointment of Mr. Vinod Kumar Sharma as Independent Director, and re-appointment of executive directors Mr. Ramesh Arora (Managing Director), Mr. Ajay Kumar Arora, Mrs. Anju Arora, and Mrs. Geeta Arora (Whole Time Directors) along with their remuneration. Re-appointment of Independent Director Mr. Kartik Kapur and ratification of Secretarial and Cost Auditors' remuneration were also approved. Out of 11,775 total shareholders on record date, 7 promoter group members and 29 public shareholders attended via VC, with approximately 43.7% of total share capital voting.
Routine procedural filing with all resolutions comfortably passed; no material governance or business changes expected. Shareholders should note the continued re-appointment and remuneration approval for promoter-family executive directors, which may be of interest to public shareholders concerned about related-party remuneration.